申请人:Norwich Eaton Pharmaceuticals, Inc.
公开号:US04716168A1
公开(公告)日:1987-12-29
The present invention involves compounds of the class of imidazo[4,5-f]quinolines and methods for enhancing the immune response system of mammals which comprises systemically administering to mammals having a depressed immune function an effective but nontoxic amount of a composition comprising such a compound.
本发明涉及一类咪唑并[4,5-f]喹啉化合物和增强哺乳动物免疫反应系统的方法,其包括向免疫功能受损的哺乳动物全身给予含有此类化合物的组合物的有效但无毒量。